BOLLI, NICCOLO'
 Distribuzione geografica
Continente #
NA - Nord America 850
EU - Europa 724
AS - Asia 186
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
Totale 1.771
Nazione #
US - Stati Uniti d'America 848
IE - Irlanda 214
UA - Ucraina 151
SE - Svezia 90
IT - Italia 88
CN - Cina 73
DE - Germania 55
HK - Hong Kong 48
FI - Finlandia 44
VN - Vietnam 39
RU - Federazione Russa 29
GB - Regno Unito 20
TR - Turchia 15
BE - Belgio 12
CH - Svizzera 5
MA - Marocco 5
UZ - Uzbekistan 5
FR - Francia 4
BR - Brasile 3
EU - Europa 3
SG - Singapore 3
AT - Austria 2
GR - Grecia 2
ID - Indonesia 2
NL - Olanda 2
PL - Polonia 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
CZ - Repubblica Ceca 1
IN - India 1
MX - Messico 1
PA - Panama 1
Totale 1.771
Città #
Dublin 214
Chandler 213
San Mateo 110
Beijing 60
Ann Arbor 55
Jacksonville 53
Hong Kong 45
Dong Ket 39
Medford 38
Princeton 37
Wilmington 35
Andover 30
Perugia 26
Altamura 23
Lawrence 19
Izmir 15
Boardman 12
Brussels 12
Norwalk 12
Saint Petersburg 10
Ashburn 9
San Paolo di Civitate 9
Woodbridge 9
Des Moines 8
New York 8
Helsinki 7
Redwood City 6
Auburn Hills 4
Los Angeles 4
Shanghai 4
Moscow 3
Nürnberg 3
Phoenix 3
Rome 3
Simi Valley 3
Burlington 2
Casablanca 2
Central 2
Falls Church 2
Houston 2
Milan 2
Nanjing 2
Parma 2
Tappahannock 2
Terni 2
Aigaleo 1
Arezzo 1
Assisi 1
Baotou 1
Benslimane 1
Bologna 1
Central District 1
Changsha 1
Chengdu 1
Costa Mesa 1
Dakhla 1
Dearborn 1
Den Haag 1
Diadema 1
Edinburgh 1
Fremont 1
Hanover 1
Hebei 1
Ludwigshafen 1
Macclesfield 1
Mexico City 1
Mohammedia 1
Monte San Savino 1
Mountain View 1
Ningbo 1
Panama City 1
San Diego 1
Shenyang 1
Southend 1
Umbertide 1
Zhongxin 1
Totale 1.192
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 101
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 89
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 86
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 80
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. 72
WHOLE EXOME SEQUENCING DEFINES CLONAL ARCHITECTURE AND GENOMIC EVOLUTION IN MULTIPLE MYELOMA 65
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 58
Prognostic impact of genetic characterization in the GIMEMA LAM99P study for newly diagnosed adult AML. Relevance of combined analysis of conventional karyotyping, FLT3 and NPM mutational status 57
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 57
WESTERN BLOT IDENTIFICATION OF NPM1 LEUKEMIC MUTANTS IN CYTOLOGICAL AML SAMPLES: A POWERFUL DIAGNOSTIC TECHNIQUE 55
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 54
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 53
Cleavage and Polyadenylation Specificity Factor 1 Is Required for Definitive Hematopoietic Stem Cell Survival In Zebrafish. 52
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 52
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 52
Manuale Merck di Diagnosi e Terapia (V edizione Italiana) 50
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice 49
Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia 48
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia 46
BORN TO BE EXPORTED: C-TERMINUS NUCLEAR EXPORT SIGNALS OF DIFFERENT STRENGTH ENSURE CYTOPLASMIC ACCUMULATION OF NUCLEOPHOSMIN LEUKEMIC MUTANTS 45
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 45
EXPRESSION OF THE CYTOPLASMIC NPM1 MUTANT (NPMC+) CAUSES THE EXPANSION OF HEMATOPOIETIC CELLS IN ZEBRAFISH 42
Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb. 42
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin 42
Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish. 40
Function of Nucleophosmin in Zebrafish Hematopoiesis 40
DOSE-DEPENDENT COMPETITION BETWEEN NPM LEUKEMIC MUTANTS AND ARF PROTEIN FOR SUBCELLULAR DISTRIBUTION: A NUCLEAR TUG-OF-WAR 40
CYTOPLASMIC MUTATED NUCLEOPHOSMIN DEFINES THE MOLECULAR STATUS OF A SIGNIFICANT FRACTION OF MYELOID SARCOMAS 38
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML. 37
Upregulation of eIF4E in Nucleophosmin 1 (NPM1) Haploinsufficient Cells Alters CCAAT Enhancer Binding Protein Alpha (C/EBP{alpha}) Activity: Implications for MDS and AML 36
cpsf1 is required for definitive HSC survival in zebrafish. 35
Reciprocal Interaction between NPM Leukemic Mutants and Arf: Structural Basis and Functional Consequences 34
Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. 33
null 29
Tumor Protein D52 (TPD52): A Novel B Cell/Plasma Cell Molecule Identified through a Proteomic Approach and Characterized by Unique Expression Pattern and Ca2+-Dependent Association with Annexin VI 28
Human Nucleophosmin (NPM1) Perturbs Myeloid Development in Zebrafish in Vivo 26
The Role of RNA Helicase Dead Box 18 in Zebrafish Hematopoiesis and Human MDS 23
Tumor protein D52 (TPD52): A novel B-cell/plasma cell molecule with unique expression pattern and Ca2+-dependent association with Annexin VI. 17
Totale 1.848
Categoria #
all - tutte 6.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201924 0 0 0 0 0 0 0 0 0 0 18 6
2019/2020132 3 4 13 3 13 4 14 1 33 24 5 15
2020/2021340 2 33 9 33 88 18 21 2 19 9 60 46
2021/2022342 11 82 4 18 19 2 3 112 5 4 38 44
2022/2023655 43 107 2 65 45 65 0 25 264 3 25 11
2023/2024138 17 23 9 11 5 1 53 10 4 4 1 0
Totale 1.848